Pentoxifylline and cerebrovascular diseases

Area of Science:

• Pharmacology
• Hematology
• Neurology

Background:

• Red blood cell deformability is crucial for microcirculation.
• Impaired red cell deformability is linked to cerebrovascular conditions.
• Pentoxifylline is investigated for its hemorheologic properties.

Purpose of the Study:

• To review the efficacy of Pentoxifylline in cerebrovascular impairment.
• To examine Pentoxifylline's effects on red cell deformability and blood flow.
• To summarize clinical and hemodynamic parameter improvements.

Main Methods:

• Review of multiple double-blind clinical trials.
• Analysis of Pentoxifylline's impact on red blood cell rheology.
• Assessment of hemodynamic and clinical outcomes.

Main Results:

• Pentoxifylline enhances red blood cell deformability.
• The drug favorably influences regional blood flow.
• Clinical efficacy is supported by numerous studies.

Conclusions:

• Pentoxifylline demonstrates effectiveness in treating cerebrovascular impairment.
• Restoration of red cell deformability is a key mechanism.
• The drug offers benefits for hemodynamic and clinical parameters.